Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

References

Page 1

	Year	Citations
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer Anthony V. D’Amico JAMA	1998	4.5K
Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer Martin G. Sanda, Nicholas P. Restifo, Jessica C. Walsh, JNCI Journal of the National Cancer Institute	1995	238
Loss of HLA class I expression in prostate cancer: Implications for immunotherapy Rosemary A. Blades, Patrick Keating, L J McWilliam, Urology HistocompatibilityCancer ImmunosurveillanceMedicineHla ImmunogeneticsImmunology	1995	194
HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Marco Vitale, Rita Rezzani, Luigi Fabrizio Rodella, PubMed HistocompatibilityCancer ImmunosurveillanceBreast OncologyMedicineBreast Carcinoma Lesions	1998	171
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma Ana Belén Campo, Jon Amund Kyte, Javier Carretero, International Journal of Cancer ImmunologyPathologyImmunotherapeuticsImmunotherapyCancer Biology	2013	140
HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker Giuseppe Sconocchia, Serenella Eppenberger‐Castori, Inti Zlobec, Neoplasia	2014	139
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer José María Romero, Pilar Jiménez, Teresa Cabrera, International Journal of Cancer Antigen Presentation MachineryUrologyCancer ImmunosurveillanceMhc ClassGenitourinary Cancer	2004	137
Beta2‐microglobulin mutations in microsatellite unstable colorectal tumors Matthias Kloor, Sara Michel, Boris Buckowitz, International Journal of Cancer Msi-h CancersMedicineImmunologyBeta2‐microglobulin MutationsPathology	2007	115
NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner Andreas Neerincx, Galaxia M. Rodriguez, Viktor Steimle, The Journal of Immunology Adaptive Immune SystemImmunologyImmunologic MechanismAntigen ProcessingInnate Immunity	2012	111
β2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis Wen‐Chin Huang, Daqing Wu, Zhihui Xie, Cancer Research	2006	111

Page 1